14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
AZUL vs GOCO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, GoHealth, Inc. (GOCO) is the stronger overall head-to-head candidate over AZUL (AZUL) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AZUL carries a Unified Composite Score of 48.4/100 (HOLD) at $3.88 (N/M Forward P/E, N/A operating margin), whereas GOCO carries 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin).
Composite vs. Pillar Nuance: While AZUL currently prints a higher short-term Unified Composite Score (48.4/100 HOLD vs. GOCO 42.9/100 HOLD), GOCO captures the overall institutional head-to-head verdict (5–3 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-292.0% vs. N/A operating margin) and revenue trajectory (-94.6% vs. N/A YoY).
Technical & Structure Timing Caution: AZUL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.2); meanwhile GOCO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AZUL vs GOCO. Trailing 12-month operating profitability (AZUL N/A vs GOCO -292.0%) and valuation multiples (AZUL N/M vs GOCO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance Brokers value chain with $8.5M market capitalization and -292.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ AZUL vs GOCO Key Questions & Quantitative Answers
As of Nov 17, 2026, GoHealth, Inc. (GOCO) is the stronger overall head-to-head candidate over AZUL (AZUL) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AZUL carries a Unified Composite Score of 48.4/100 (HOLD) at $3.88 (N/M Forward P/E, N/A operating margin), whereas GOCO carries 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin). Composite vs. Pillar Nuance: While AZUL currently prints a higher short-term Unified Composite Score (48.4/100 HOLD vs. GOCO 42.9/100 HOLD), GOCO captures the overall institutional head-to-head verdict (5–3 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-292.0% vs. N/A operating margin) and revenue trajectory (-94.6% vs. N/A YoY). Technical & Structure Timing Caution: AZUL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.2); meanwhile GOCO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
GOCO leads the Growth & Scale pillar: AZUL posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with GOCO at -94.6% YoY revenue growth and +424.1% YoY earnings growth on $153M TTM revenue (57.3% gross margin, -292.0% operating margin). On trailing 12-month operating scale, AZUL generates N/A in USD-normalized revenue versus $153M for GOCO. In operating R&D and SG&A reinvestment, AZUL deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GOCO.
GOCO screens cheaper on headline valuation multiples. AZUL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas GOCO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-96.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AZUL (N/A ROE) versus GOCO (-289.9% ROE) capital efficiency.
In options market volatility and institutional positioning, AZUL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.14β · 157% Vol realized risk). By comparison, GOCO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.15β · 201% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.